Original Research
Accepted on 20 Jan 2026
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
in Thoracic Oncology
- 130 views